201 Haskins Way
Suite 230
South San Francisco, CA 94080
United States
215-731-9450
https://www.cero.bio
Settore/i: Healthcare
Settore: Biotechnology
Impiegati a tempo pieno: 8
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Dr. Daniel Mark Corey M.D. | Founder, CTO & Director | 376,04k | N/D | 1979 |
Mr. Brian G. Atwood | President, CEO & Chairman | N/D | N/D | 1953 |
Mr. Charles Ross Carter | CFO, Treasurer & Corporate Secretary | N/D | N/D | 1968 |
Dr. Robert Sikorski M.D., Ph.D. | Consultant | N/D | N/D | 1963 |
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.
L'ISS Governance QualityScore di CERo Therapeutics Holdings, Inc. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.